PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more
Apr 19, 2016
8:51
Episode Description
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 19, 2016 issue
Proudly Supported by
